Vértesy Sabine, Michalak Malwina, Miller Michelle C, Schnölzer Martina, André Sabine, Kopitz Jürgen, Mayo Kevin H, Gabius Hans-Joachim
Institut für Physiologische Chemie, Tierärztliche Fakultät, Ludwig-Maximilians Universität, Veterinär-straße 13, 80539 München, Germany.
Abteilung für Angewandte Tumorbiologie, Pathologisches Institut, Klinikum der Ruprecht-Karls-Universität, Im Neuenheimer Feld 224, 69120 Heidelberg, Germany.
Protein Eng Des Sel. 2015 Jul;28(7):199-210. doi: 10.1093/protein/gzv014. Epub 2015 Mar 21.
Lectins translate information encoded in glycan chains of cellular glycoconjugates into bioeffects. The topological presentation of contact sites for cognate sugar binding is a crucial factor toward this end. To dissect the significance of such phylogenetically conserved properties, the design and engineering of non-natural variants are attractive approaches. Here, a homodimeric human lectin, i.e. adhesion/growth-regulatory galectin-1, is converted into a tandem-repeat display by introducing the 33-amino-acid linker of another family member (i.e. galectin-8). The yield of variant was reduced by about a third. This protein had ∼10-fold higher activity in hemagglutination. Nearly complete sequence determination by mass-spectrometric in-source decay and fingerprinting excluded the presence of any modifications. When (1)H-(15)N heteronuclear single-quantum coherence data on the (15)N-labeled variant and wild-type protein were compared, changes in chemical shifts, signal intensities and resonance multiplicities revealed reduction of stability of interfacial contacts between the lectin domains and an increase in inter-domain flexibility. When both binding sites in the variant were loaded with ligand, association of the two carbohydrate recognition domains was enhanced, corroborated by gel filtration. Dynamic changes in the spatial presentation of the two lectin domains in the context of a tandem-repeat display can alter counterreceptor targeting relative to the fixed positions found in the proto-type galectin homodimer.
凝集素将细胞糖缀合物聚糖链中编码的信息转化为生物效应。同源糖结合接触位点的拓扑呈现是实现这一目标的关键因素。为了剖析这种系统发育保守特性的重要性,非天然变体的设计和工程改造是很有吸引力的方法。在这里,一种同源二聚体人凝集素,即黏附/生长调节半乳糖凝集素-1,通过引入另一个家族成员(即半乳糖凝集素-8)的33个氨基酸的连接子,转化为串联重复形式。变体的产量降低了约三分之一。这种蛋白质在血细胞凝集方面的活性提高了约10倍。通过质谱源内衰变和指纹图谱进行的近乎完整的序列测定排除了任何修饰的存在。当比较(1)H-(15)N异核单量子相干数据(关于(15)N标记的变体和野生型蛋白质)时,化学位移、信号强度和共振多重性的变化揭示了凝集素结构域之间界面接触稳定性的降低以及结构域间灵活性的增加。当变体中的两个结合位点都负载配体时,凝胶过滤证实了两个碳水化合物识别结构域的结合增强。在串联重复形式的背景下,两个凝集素结构域空间呈现的动态变化可以改变相对于原型半乳糖凝集素同源二聚体中固定位置的反受体靶向。